D Molecular Therapeutics, Inc. ( (FDMT) ) has released its Q3 earnings. Here is a breakdown of the information 4D Molecular Therapeutics, Inc.
In a report released today, Greg Harrison from Scotiabank maintained a Buy rating on Rocket Pharmaceuticals (RCKT – Research Report), ...
Large-cap stocks just saw their biggest-ever week of purchases, according to Bank of America data.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback